methotrexate has been researched along with Dysmyelopoietic Syndromes in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (4.35) | 18.7374 |
| 1990's | 25 (36.23) | 18.2507 |
| 2000's | 25 (36.23) | 29.6817 |
| 2010's | 13 (18.84) | 24.3611 |
| 2020's | 3 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Billick, M; Liu, J; Monsour, D; Wang, X | 1 |
| Al-Kali, A; Alkhateeb, HB; Dudek, AZ; McTavish, H; Patnaik, MM; Wallerich, S; Zblewski, DL | 1 |
| Arber, D; Avigan, DE; Foss, FM; Gascoyne, RD; Hogan, WJ; Horning, SJ; Jegede, O; Lazarus, HM; Litzow, MR; Luger, SM; Miller, KB; Sprague, KA; Stadtmauer, EA; Strair, RK; Tallman, MS; Wagner, H; Wang, XV; Whiteside, TL | 1 |
| Buizen, L; Butler, JP; Chang, K; Cooney, J; Curley, C; Durrant, S; Gartlan, KH; Gottlieb, D; Henden, AS; Hill, GR; Kennedy, GA; Misra, A; Moore, J; Morton, AJ; Olver, SD; Paul, SK; Ritchie, D; Subramoniapillai, E; Tey, SK; Varelias, A | 1 |
| Cammelli, D; Palterer, B; Vitiello, G | 1 |
| Alyea, EP; Artz, A; Boyer, MW; Chen, YB; DiPersio, JF; Gergis, U; Glavin, F; Ho, VT; Holter, J; Horwitz, ME; Jagasia, MH; Johnston, L; Kim, HT; Levine, JD; Lewis, ID; Martin, PJ; Maziarz, RT; McGuirk, J; Patnaik, MM; Pidala, JA; Porter, DL; Reshef, R; Ritz, J; Rybka, W; Safah, H; Shaughnessy, PJ; Shea, TC; Soiffer, RJ; Stiff, PJ; Szer, J; Vusirikala, M; Westervelt, P | 1 |
| Abdel-Azim, H; Aljurf, MD; Alousi, AM; Antin, JH; Arora, M; Cahn, JY; Chhabra, S; Cooper, B; Costa, L; Couriel, DR; Gale, RP; Gergis, U; Hamilton, BK; Hashmi, SK; Hayashi, RJ; Hematti, P; Hemmer, MT; Inamoto, Y; Kamble, RT; Kim, D; Lehmann, L; Litzow, MR; Liu, Y; MacMillan, ML; Majhail, NS; Marks, DI; Martino, R; Nishihori, T; Pidala, JA; Qayed, M; Ringden, O; Saad, A; Savani, BN; Schoemans, H; Schouten, HC; Seo, S; Socie, G; Solh, MM; Spellman, SR; Stuart, RK; Teshima, T; Urbano-Ispizua, A; Verdonck, LF; Vij, R; Wagner, J; Yared, J | 1 |
| Gao, YT; Qian, LL; Shen, JP; Wen, XW; Ye, BD; Zhang, Y; Zhou, YH | 1 |
| Cabanillas, F; Cheah, CY; Chihara, D; Fayad, LE; Goy, A; Hagemeister, FB; Kantarjian, H; Kwak, LW; McLaughlin, P; Pro, B; Rodriguez, MA; Romaguera, JE; Samaniego, F; Wang, ML; Westin, JR; Younes, A | 1 |
| Abu Zaid, M; Antin, JH; Choi, SW; Cutler, C; Logan, BR; Paczesny, S; Wu, C; Wu, J; Yu, J | 1 |
| Al-Kali, A; Castro, J; Dueck, A; Ertz-Archambault, N; Finn, L; Foran, J; Gauthier, S; Kelemen, K; Kosiorek, H; Marino, R; Mesa, RA; Palmer, J; Sproat, LZ; Taylor, GE; Tibes, R | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Wang, Y; Xu, LP | 1 |
| Ikeda, K; Iwadate, H; Kobayashi, H; Ogawa, K; Ohira, H; Watanabe, H; Yano, K | 1 |
| Akashi, K; Fukagawa, S; Furue, M; Miyamoto, T; Moroi, Y; Sugiyama, A; Takeuchi, S; Yoshimoto, G | 1 |
| Busemann, C; Dölken, G; Kiefer, T; Krüger, WH; Neumann, T; Wilfert, H | 1 |
| Bertz, H; Engelhardt, M; Finke, J; Grüllich, C; Ihorst, G; Marks, R; Spyridonidis, A; Wäsch, R | 1 |
| Advani, RH; Balise, R; Greenberg, PL; Hoppe, RT; Horning, SJ; Koontz, MZ; Rosenberg, SA | 1 |
| Estey, E; Garcia-Manero, G; Kantarjian, HM; Kornblau, S | 1 |
| Jaffe, BM; Kahn, MJ; Weldon, CB | 1 |
| Fischer, G; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Lechner, K; Mayr, W; Mitterbauer, M; Worel, N | 1 |
| Aoki, K; Chiba, S; Goyama, S; Hirai, H; Kanda, Y; Kandabashi, K; Kawazu, M; Komeno, Y; Kurokawa, M; Motokura, T; Nakamoto, T; Nannya, Y; Niino, M; Ogawa, S; Takeshita, M; Tsujino, S | 1 |
| Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Asahara, S; Chinzei, T; Kawano, S; Koshiba, M; Kumagai, S; Maekawa, S; Nakamura, T; Nobuhara, Y; Saigo, K; Tsuji, G | 1 |
| Kamatani, N; Okamoto, H; Teramura, M | 1 |
| Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M | 1 |
| Fay, MJ; Murphy, PT; O'Donnell, JR; Quinn, JP; Swords, RT | 1 |
| Fenk, R; Germing, U; Graef, T; Haas, R; Hinke, A; Kobbe, G; Neumann, F; Steidl, U; Tapprich, C; Vaupel, M | 1 |
| Aisa, Y; Ikeda, Y; Ishida, A; Mori, T; Okamoto, S; Uemura, T; Yamada, Y | 1 |
| Boulad, F; Castro-Malaspina, H; Chiu, M; Heller, G; Hsu, K; Jakubowski, A; Kernan, NA; O'Reilly, RJ; Papadopoulos, EB; Perales, MA; Prockop, S; Small, TN; Wilton, A; Young, JW | 1 |
| Hara, M; Hino, M; Hori, A; Kami, M; Kanda, Y; Kim, SW; Mineishi, S; Mori, S; Ohashi, Y; Saito, AM; Suzuki, R; Takami, A; Takaue, Y; Takemoto, Y; Taniguchi, S; Yamaguchi, M; Yoshida, T | 1 |
| Aisa, Y; Ikeda, Y; Mihara, A; Mori, T; Nakazato, T; Okamoto, S; Shimizu, T; Yamane, A; Yamazaki, R | 1 |
| Chen, H; Chen, Y; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Lu, DP; Shi, HX; Wang, JZ; Wang, Y; Xu, LP; Zhang, XU; Zhang, YC | 1 |
| Ayuk, F; Bacher, U; Binder, T; Diyachenko, G; Eiermann, T; Erttmann, R; Fehse, B; Kabisch, H; Kröger, N; Panse, J; Wolschke, C; Zabelina, T; Zander, AR | 1 |
| Chan, T; Cooper, I; Januszewicz, E; Juneja, S; Wolf, M | 1 |
| Hotta, T; Ichikawa, A; Ito, T; Kagami, Y; Ohashi, H; Saito, H | 1 |
| Attal, M; Brousset, P; Dastugue, N; Demur, C; Duchayne, E; Rigal-Huguet, F; Robert, A; Rubie, H | 1 |
| Bennett, RM; Kohli, M | 1 |
| Favre, H; Lemoine, R; Miescher, PA | 1 |
| Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
| Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A | 1 |
| Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
| Buck, SA; Gurney, JG; Matherly, LH; Ravindranath, Y; Stout, ML; Taub, JW | 1 |
| Cremin, P; Daly, PA; Flattery, M; McCann, SR | 1 |
| Farhi, DC; Rosenthal, NS | 1 |
| Burnett, AK; Goldstone, AH; Gray, RG; Hann, IM; Rees, JK; Stevens, RF; Wheatley, K | 1 |
| Bertz, H; Finke, J; Mertelsmann, R; Potthoff, K | 1 |
| Bayle, C; Corti, C; Cosset, JM; Girinsky, T; Hayat, M; Nasr, F; Ribrag, V; Rougier, P; Theodore, C | 1 |
| Antin, JH; Ballen, KK; Bierer, BE; Ferrara, JL; Gilliland, DG; Guinan, EC; Hsieh, CC; Parsons, SK; Rimm, IJ; Weinstein, HJ | 1 |
| Amemiya, Y; Furukawa, Y; Hoshino, M; Imagawa, S; Izumi, T; Kawano, C; Kirito, K; Komatsu, N; Kuribara, R; Miura, Y; Miyazato, A; Muroi, K; Omine, K; Otsuki, T; Shimizu, R; Suzuki, T; Tabata, M; Takahashi, H; Takatoku, M; Terui, Y; Tomizuka, H; Toshima, M; Tsunoda, J; Uchida, M; Yoshida, M | 1 |
| Lowdell, CP; Partridge, SE | 1 |
| Beuge, N; de Groot, K; Gross, WL; Heller, M; Latza, U; Nölle, B; Reinhold-Keller, E; Rudert, H | 1 |
| Albrechtsen, D; Brinch, L; Egeland, T; Evensen, SA; Heldal, D; Solheim, BG; Steen, R; Tjønnfjord, G | 1 |
| Ashley, S; Kuan, A; Kulkarni, S; Mehta, J; Mitchell, P; Powles, R; Powles, T; Saso, R; Swansbury, GJ; Treleaven, J | 1 |
| Durrant, S; Irving, I; Mollee, P; Morton, AJ | 1 |
| Akiyoshi, K; Eguchi, H; Hara, T; Inada, H; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nagatoshi, Y; Nakayama, H; Nibu, K; Okamura, J; Take, H; Tamai, Y; Yanai, F | 1 |
| Kabisch, H; Kröger, N; Krüger, W; Renges, H; Schetelig, J; Schrum, J; Siegert, W; Stute, N; Zabelina, T; Zander, AR | 1 |
| Gati, WP; Larratt, LM; Turner, AR | 1 |
| Dubost, JJ; Fournier, P; Guillemot, C; Ristori, JM; Soubrier, M | 1 |
| Bessell, EM; Hunter, AE; Russell, NH | 1 |
| Calhoun, L; Champlin, RE; Gajewski, JL; Ho, WG; Hunt, LA; Landaw, EM; Lyddane, NR; O'Rourke, S; Petz, LD; Schiller, GJ | 1 |
| Buchanan, GR; Pappo, A; Sanders, JM; Schneider, NR | 1 |
| Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC | 1 |
| Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S | 1 |
| Badía, L; Beneyto, M; Martínez-Castellano, F; Montero, MR; Palau, F; Prieto, F | 1 |
| Crocker, I; Dobbs, CK; Gordon, DS; Heffner, LT; Reynolds, R; Sternberg, P; Vogler, WR; Winton, EF | 1 |
| Anasetti, C; Appelbaum, FR; Beatty, P; Doney, K; Martin, P; Pepe, M; Stewart, P; Storb, R; Sullivan, KM; Witherspoon, R | 1 |
| Conter, V; D'Incalci, M; Erba, E; Masera, G; Perlangeli, MV; Rabbone, ML; Sen, S | 1 |
| Cunningham, JJ; Potter, AM; Watmore, AE; Winfield, DA | 1 |
| Buchbinder, R; Hall, S; Harkness, AJ; Littlejohn, GO; Ryan, PF | 1 |
3 review(s) available for methotrexate and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Growth Disorders; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Infant; Japan; Male; Methotrexate; Myelodysplastic Syndromes; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Survivors; Treatment Outcome; Vincristine | 2001 |
Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Methotrexate; Myelodysplastic Syndromes; Osteosarcoma | 1991 |
[Importance of cytogenetics in the study of acute non-lymphoblastic leukemias].
Topics: Bone Marrow Examination; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Humans; Leukemia, Myeloid, Acute; Methotrexate; Myelodysplastic Syndromes; Neoplasms, Multiple Primary; Proto-Oncogenes; Translocation, Genetic | 1991 |
22 trial(s) available for methotrexate and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Phase 1b Study of IGF-Methotrexate Conjugate in the Treatment of High-grade Myelodysplastic Syndromes.
Topics: Aged; Aged, 80 and over; Humans; Immunoconjugates; Insulin-Like Growth Factor I; Male; Methotrexate; Molecular Targeted Therapy; Myelodysplastic Syndromes; Neoplasm Grading; Receptor, IGF Type 1 | 2020 |
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Topics: Adult; Allografts; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Pentostatin; Photopheresis; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2020 |
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Cyclosporine; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Placebo Effect; Transplantation, Homologous; Treatment Outcome | 2021 |
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Tacrolimus; Young Adult | 2017 |
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Topics: Adult; Aged; Allografts; Calcineurin Inhibitors; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Retrospective Studies; Siblings; Survival Rate; Tacrolimus; Transplantation Conditioning | 2019 |
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Rituximab; Vincristine | 2016 |
Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.
Topics: Adolescent; Adult; Allografts; Area Under Curve; Biomarkers, Tumor; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; ROC Curve; Sensitivity and Specificity; Sirolimus; Tacrolimus; Transplantation, Homologous; Young Adult | 2017 |
First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Transplantation, Homologous | 2009 |
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors | 2004 |
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Leukemia, Myeloid, Acute; Male; Melphalan; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Survival Analysis; Tacrolimus; Transplantation Conditioning | 2007 |
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Topics: Adult; Aged; Busulfan; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Postoperative Complications; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2007 |
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Survival Rate; Transplantation Conditioning | 2008 |
Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplastic syndromes.
Topics: Anemia, Refractory; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Methotrexate; Myelodysplastic Syndromes; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Use of cyclosporine in the treatment of autoimmune disorders.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence | 1994 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Myelodysplasia and acute myeloid leukaemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Mitomycins; Mitoxantrone; Myelodysplastic Syndromes; Pilot Projects; Prevalence; Prognosis; Survival Rate | 1996 |
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medica
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Hydrocortisone; Infant; Leukemia, Myeloid; Life Tables; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Patient Compliance; Remission Induction; Survival Analysis; Thioguanine; Treatment Outcome | 1997 |
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 1997 |
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
Topics: Adolescent; Adult; Bone Marrow Cells; Cyclosporine; Family; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Leukocyte Count; Living Donors; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Primary Myelofibrosis; Survival Analysis; Transplantation, Homologous | 2000 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome | 1991 |
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Topics: Acute Disease; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Cyclosporins; Etoposide; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppression Therapy; Leukemia; Male; Methotrexate; Myelodysplastic Syndromes; Prednisone; Random Allocation; Risk Factors; Whole-Body Irradiation | 1990 |
44 other study(ies) available for methotrexate and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Central nervous system graft-versus-host disease in a 68-year-old man presenting with myoclonus.
Topics: Aged; Brain Diseases; Central Nervous System Diseases; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Myelodysplastic Syndromes; Myoclonus; Pulse Therapy, Drug; Transplantation, Homologous | 2019 |
First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome.
Topics: Aged; Anemia, Megaloblastic; Biomarkers; Dermatologic Agents; Dermatomyositis; Drug Therapy, Combination; Fatal Outcome; Female; Glucocorticoids; Humans; Immunoglobulins; Isoantibodies; Methotrexate; Myelodysplastic Syndromes; Pneumonia, Aspiration; Risk Factors | 2017 |
[Treatment of myelodysplastic syndrome by hematopoietic stem cell transplantation combined with Chinese medical syndrome typing: a clinical study].
Topics: Biomedical Research; Blood Platelets; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drugs, Chinese Herbal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Medicine, Chinese Traditional; Methotrexate; Myelodysplastic Syndromes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2015 |
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Case-Control Studies; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myeloid, Acute; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Mycophenolic Acid; Myelodysplastic Syndromes; Odds Ratio; Psoriasis; Retrospective Studies; Risk Factors; United States | 2017 |
Therapy-related myelodysplastic syndrome following cyclophosphamide pulse and/or methotrexate therapy in a patient with systemic lupus erythematosus.
Topics: Adult; Bone Marrow Cells; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methotrexate; Myelodysplastic Syndromes; Pancytopenia | 2010 |
Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation.
Topics: Bone Marrow Transplantation; Diabetes Mellitus, Type 2; Edema; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Insulin; Leg; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Skin Diseases; Tacrolimus; Treatment Outcome | 2012 |
Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukocyte Count; Lymphoma; Male; Methotrexate; Middle Aged; Mucositis; Myelodysplastic Syndromes; Platelet Count; Statistics as Topic; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2011 |
Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Germany; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Secondary Prevention; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors | 2012 |
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; California; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dacarbazine; Databases, Factual; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Melphalan; Methotrexate; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Risk; Vinblastine; Vincristine | 2013 |
Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Remission Induction; Tretinoin; Vincristine | 2002 |
Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Fatal Outcome; Female; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Tamoxifen | 2002 |
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
Topics: ABO Blood-Group System; Adolescent; Adult; Aged; Anemia, Hemolytic; B-Lymphocytes; Blood Group Incompatibility; Carcinoma, Renal Cell; Erythrocyte Transfusion; Female; Graft vs Host Disease; Hematologic Neoplasms; Hemolysis; Humans; Immunosuppressive Agents; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Peripheral Blood Stem Cell Transplantation; Prevalence; Rh-Hr Blood-Group System; Survival Analysis; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2002 |
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence; Remission Induction; Tissue Donors; Transplantation Chimera; Transplantation Conditioning | 2003 |
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Dermatomyositis and myelodysplastic syndrome with myelofibrosis responding to methotrexate therapy.
Topics: Blood Cells; Bone Marrow Cells; Dermatomyositis; Humans; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Primary Myelofibrosis; Treatment Outcome | 2003 |
Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis.
Topics: Administration, Oral; Arthritis, Rheumatoid; Bone Marrow Cells; Female; Humans; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Pancytopenia | 2004 |
Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 2004 |
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Siblings; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation.
Topics: Adenoviridae Infections; Adrenal Cortex Hormones; Adult; Anemia, Hemolytic, Autoimmune; Bone Marrow Transplantation; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Methotrexate; Myelodysplastic Syndromes; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
Topics: Adult; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Leukemia; Leukocyte Count; Lymphoma; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Probability; Tacrolimus; Transplantation Conditioning | 2007 |
[Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Prednisone; Procarbazine; Rectal Neoplasms; Risk Factors; Seminoma; Testicular Neoplasms; Transplantation, Autologous; Vincristine | 1994 |
Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Female; Hematopoiesis; Humans; Methotrexate; Methylation; Middle Aged; Myelodysplastic Syndromes; Polymorphism, Restriction Fragment Length; Remission Induction | 1994 |
An association of polymyalgia rheumatica with myelodysplastic syndromes.
Topics: Aged; Blood Cell Count; Bone Marrow; Female; Humans; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Polymyalgia Rheumatica; Prednisone | 1994 |
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1993 |
Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cell Line, Transformed; Cells, Cultured; Child; Child, Preschool; Chromosomes, Human, Pair 21; Cystathionine beta-Synthase; Cytarabine; Deoxycytosine Nucleotides; Disease-Free Survival; Down Syndrome; Female; Herpesvirus 4, Human; Homocysteine; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Male; Methotrexate; Myelodysplastic Syndromes; Neoplastic Stem Cells; Remission, Spontaneous; Survival Rate | 1996 |
Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy.
Topics: Acute Disease; Adult; Aged; Antigens, CD; Antirheumatic Agents; Chlorambucil; Connective Tissue Diseases; Cyclophosphamide; Cytogenetics; Female; Humans; Leukemia, Myeloid; Leukopenia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 1996 |
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Transplantation Conditioning | 1997 |
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1996 |
[Retrospective analysis of elderly patients > or = 60 years of age with acute leukemia].
Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; DNA; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Retrospective Studies; Vincristine | 1998 |
Myelodysplastic syndrome as a complication of neo-adjuvant triple M chemotherapy and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Myelodysplastic Syndromes; Neoadjuvant Therapy; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy | 1999 |
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.
Topics: Adolescent; Adult; Aged; Cohort Studies; Cyclophosphamide; Cystitis; Female; Granulomatosis with Polyangiitis; Humans; Immunoglobulins, Intravenous; Long-Term Care; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Patient Care Team; Prednisone; Treatment Outcome | 2000 |
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; England; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Incidence; Leukemia, Myeloid; Leukemia, Radiation-Induced; Life Tables; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prospective Studies; Registries; Risk; Survival Analysis; Tamoxifen; Translocation, Genetic | 2000 |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous | 2001 |
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Bone Marrow; Busulfan; Cell Count; Chromosomes, Human, Pair 7; Cyclophosphamide; Disease-Free Survival; Feasibility Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Karyotyping; Methotrexate; Middle Aged; Monosomy; Myelodysplastic Syndromes; Recurrence; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Cellular abundance of es nucleoside transporters and differential drug toxicity in myelodysplastic syndrome (MDS) bone marrow cell subpopulations.
Topics: Adenosine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bone Marrow Cells; Carrier Proteins; Cell Survival; Cytarabine; Flow Cytometry; Fluorescent Dyes; Humans; Ligands; Membrane Proteins; Methotrexate; Myelodysplastic Syndromes; Nucleoside Transport Proteins; Thionucleosides | 2001 |
Myelodysplasia revealed by seropositive polyarthritis complicated by bicytopenia after the first methotrexate dose.
Topics: Aged; Anemia; Arthritis, Rheumatoid; Fatal Outcome; Humans; Leukopenia; Male; Methotrexate; Myelodysplastic Syndromes; Rheumatoid Factor; Serologic Tests | 2002 |
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Recurrence | 1992 |
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Topics: ABO Blood-Group System; Adult; Anemia, Aplastic; Antibodies; Blood Component Transfusion; Blood Group Incompatibility; Bone Marrow Transplantation; Coombs Test; Cyclosporine; Hemolysis; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 1992 |
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes | 1991 |
Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cerebellar Diseases; Cyclosporins; Cytarabine; Diarrhea; Evaluation Studies as Topic; Female; Georgia; Humans; Leukemia; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Preoperative Care; Remission Induction; Retinitis; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 1990 |
Induction of partial synchronization of leukemia cells by continuous infusion of low-dose methotrexate followed by citrovorum factor.
Topics: Bone Marrow; Child; Cytological Techniques; Humans; Infusions, Intravenous; Interphase; Leucovorin; Methotrexate; Myelodysplastic Syndromes; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1989 |
Methotrexate and bone marrow metaphases.
Topics: Adolescent; Adult; Aged; Bone Marrow; Cells, Cultured; Chromosome Banding; Chromosomes, Human, Pair 1; Female; Humans; Karyotyping; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Metaphase; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 1988 |
Severe bone marrow failure due to low dose oral methotrexate.
Topics: Acute Disease; Administration, Oral; Aged; Arthritis, Rheumatoid; Female; Humans; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 1988 |